FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312222011> ?p ?o ?g. }

• W4312222011 endingPage "107067" @default.
• W4312222011 startingPage "107067" @default.
• W4312222011 abstract "Timely trial start-up is a key determinant of trial success; however, delays during start-up are common and costly. Moreover, data on start-up metrics in pediatric clinical trials are sparse. To expedite trial start-up, the Trial Innovation Network piloted three novel mechanisms in the trial titled Dexmedetomidine Opioid Sparing Effect in Mechanically Ventilated Children (DOSE), a multi-site, randomized, double-blind, placebo-controlled trial in the pediatric intensive care setting.The three novel start-up mechanisms included: 1) competitive activation; 2) use of trial start-up experts, called site navigators; and 3) supplemental funds earned for achieving pre-determined milestones. After sites were activated, they received a web-based survey to report perceptions of the DOSE start-up process. In addition to perceptions, metrics analyzed included milestones met, time to start-up, and subsequent enrollment of subjects.Twenty sites were selected for participation, with 19 sites being fully activated. Across activated sites, the median (quartile 1, quartile 3) time from receipt of regulatory documents to site activation was 82 days (68, 113). Sites reported that of the three novel mechanisms, the most motivating factor for expeditious activation was additional funding available for achieving start-up milestones, followed by site navigator assistance and then competitive site activation.Study start-up is a critical time for the success of clinical trials, and innovative methods to minimize delays during start-up are needed. Milestone-based funds and site navigators were preferred mechanisms by sites participating in the DOSE study and may have contributed to the expeditious start-up timeline achieved.gov #: NCT03938857." @default.
• W4312222011 created "2023-01-04" @default.
• W4312222011 creator A5001294370 @default.
• W4312222011 creator A5016004110 @default.
• W4312222011 creator A5016604632 @default.
• W4312222011 creator A5017235975 @default.
• W4312222011 creator A5017545560 @default.
• W4312222011 creator A5018894188 @default.
• W4312222011 creator A5020588514 @default.
• W4312222011 creator A5020675273 @default.
• W4312222011 creator A5022531273 @default.
• W4312222011 creator A5023472633 @default.
• W4312222011 creator A5024270828 @default.
• W4312222011 creator A5029795207 @default.
• W4312222011 creator A5036940931 @default.
• W4312222011 creator A5040969278 @default.
• W4312222011 creator A5042561267 @default.
• W4312222011 creator A5044330615 @default.
• W4312222011 creator A5049594115 @default.
• W4312222011 creator A5052308059 @default.
• W4312222011 creator A5058826346 @default.
• W4312222011 creator A5063498406 @default.
• W4312222011 creator A5064941918 @default.
• W4312222011 creator A5065160777 @default.
• W4312222011 creator A5067298015 @default.
• W4312222011 creator A5067695269 @default.
• W4312222011 creator A5071300729 @default.
• W4312222011 creator A5075266030 @default.
• W4312222011 creator A5076556014 @default.
• W4312222011 creator A5077571151 @default.
• W4312222011 creator A5083347354 @default.
• W4312222011 creator A5084018403 @default.
• W4312222011 creator A5085031950 @default.
• W4312222011 creator A5085102489 @default.
• W4312222011 creator A5091330190 @default.
• W4312222011 date "2023-02-01" @default.
• W4312222011 modified "2023-10-10" @default.
• W4312222011 title "Mechanisms to expedite pediatric clinical trial site activation: The DOSE trial experience" @default.
• W4312222011 cites W2107185109 @default.
• W4312222011 cites W2564790786 @default.
• W4312222011 cites W2734342537 @default.
• W4312222011 cites W2783310654 @default.
• W4312222011 cites W2885447570 @default.
• W4312222011 cites W3039902676 @default.
• W4312222011 cites W3087107000 @default.
• W4312222011 cites W3159916725 @default.
• W4312222011 doi "https://doi.org/10.1016/j.cct.2022.107067" @default.
• W4312222011 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36577492" @default.
• W4312222011 hasPublicationYear "2023" @default.
• W4312222011 type Work @default.
• W4312222011 citedByCount "1" @default.
• W4312222011 crossrefType "journal-article" @default.
• W4312222011 hasAuthorship W4312222011A5001294370 @default.
• W4312222011 hasAuthorship W4312222011A5016004110 @default.
• W4312222011 hasAuthorship W4312222011A5016604632 @default.
• W4312222011 hasAuthorship W4312222011A5017235975 @default.
• W4312222011 hasAuthorship W4312222011A5017545560 @default.
• W4312222011 hasAuthorship W4312222011A5018894188 @default.
• W4312222011 hasAuthorship W4312222011A5020588514 @default.
• W4312222011 hasAuthorship W4312222011A5020675273 @default.
• W4312222011 hasAuthorship W4312222011A5022531273 @default.
• W4312222011 hasAuthorship W4312222011A5023472633 @default.
• W4312222011 hasAuthorship W4312222011A5024270828 @default.
• W4312222011 hasAuthorship W4312222011A5029795207 @default.
• W4312222011 hasAuthorship W4312222011A5036940931 @default.
• W4312222011 hasAuthorship W4312222011A5040969278 @default.
• W4312222011 hasAuthorship W4312222011A5042561267 @default.
• W4312222011 hasAuthorship W4312222011A5044330615 @default.
• W4312222011 hasAuthorship W4312222011A5049594115 @default.
• W4312222011 hasAuthorship W4312222011A5052308059 @default.
• W4312222011 hasAuthorship W4312222011A5058826346 @default.
• W4312222011 hasAuthorship W4312222011A5063498406 @default.
• W4312222011 hasAuthorship W4312222011A5064941918 @default.
• W4312222011 hasAuthorship W4312222011A5065160777 @default.
• W4312222011 hasAuthorship W4312222011A5067298015 @default.
• W4312222011 hasAuthorship W4312222011A5067695269 @default.
• W4312222011 hasAuthorship W4312222011A5071300729 @default.
• W4312222011 hasAuthorship W4312222011A5075266030 @default.
• W4312222011 hasAuthorship W4312222011A5076556014 @default.
• W4312222011 hasAuthorship W4312222011A5077571151 @default.
• W4312222011 hasAuthorship W4312222011A5083347354 @default.
• W4312222011 hasAuthorship W4312222011A5084018403 @default.
• W4312222011 hasAuthorship W4312222011A5085031950 @default.
• W4312222011 hasAuthorship W4312222011A5085102489 @default.
• W4312222011 hasAuthorship W4312222011A5091330190 @default.
• W4312222011 hasConcept C120060458 @default.
• W4312222011 hasConcept C126322002 @default.
• W4312222011 hasConcept C141071460 @default.
• W4312222011 hasConcept C166957645 @default.
• W4312222011 hasConcept C168563851 @default.
• W4312222011 hasConcept C535046627 @default.
• W4312222011 hasConcept C71924100 @default.
• W4312222011 hasConcept C95457728 @default.
• W4312222011 hasConceptScore W4312222011C120060458 @default.
• W4312222011 hasConceptScore W4312222011C126322002 @default.
• W4312222011 hasConceptScore W4312222011C141071460 @default.
• W4312222011 hasConceptScore W4312222011C166957645 @default.
• W4312222011 hasConceptScore W4312222011C168563851 @default.

• next